Krystal Biotech, Inc. KRYS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $501.31M+1.0% | $496.3M+26.4% | $392.6M+11.0% | $353.83M+14.6% | $308.77M-10.5% | ||
| $322.09M-2.8% | $331.49M-2.1% | $338.47M+3.1% | $328.16M+6.5% | $308.08M+21.9% | ||
| $495.52M+5.0% | $471.76M+5.1% | $449.08M+7.8% | $416.74M+2.0% | $408.54M-0.4% | ||
| $151.79M+9.1% | $139.09M+11.2% | $125.12M+18.0% | $106.07M+21.6% | $87.21M+27.7% | ||
| $1.02B-0.5% | $1.02B+10.7% | $925.65M+10.0% | $841.35M+9.7% | $766.8M+3.3% | ||
| $153.58M+1.9% | $150.78M+1.3% | $148.87M-1.0% | $150.39M-0.5% | $151.07M-2.6% | ||
| $1.4B+4.7% | $1.33B+7.6% | $1.24B+8.9% | $1.14B+6.0% | $1.07B+1.8% | ||
| $4.09M+26.3% | $3.24M+54.4% | $2.1M-70.6% | $7.12M+167% | $2.67M-46.4% | ||
| $107.8M+4.7% | $102.94M+12.8% | $91.27M+5.0% | $86.9M+9.3% | $79.49M-22.1% | ||
| $120.24M+5.3% | $114.23M+11.8% | $102.22M+4.6% | $97.75M+8.9% | $89.74M-18.0% | ||
| 80M0.0% | 80M0.0% | 80M0.0% | 80M0.0% | 80M— | ||
| $80.1M+231% | $24.16M+189% | -$27.24M+74.4% | -$106.6M+26.4% | -$144.94M+19.8% | ||
| $1.28B+4.7% | $1.22B+7.2% | $1.14B+9.3% | $1.04B+5.7% | $984.67M+4.0% | ||
| $1.4B+4.7% | $1.33B+7.6% | $1.24B+8.9% | $1.14B+6.0% | $1.07B+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Krystal Biotech, Inc.'s total assets?
- Krystal Biotech, Inc. (KRYS) holds $1.4B in total assets, up 30.0% year over year.
- How much debt does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. carries $9.1M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Krystal Biotech, Inc. have?
- Krystal Biotech, Inc. holds $501.3M in cash and equivalents.
- Can Krystal Biotech, Inc. cover its short-term obligations?
- Its current ratio is 9.46 — current assets exceed current liabilities.
- Where does Krystal Biotech, Inc.'s balance sheet data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
